Incretins Role in the Pathophysiology of Type 2 Diabetes Mellitus

被引:0
|
作者
Mythili, S., V [1 ]
机构
[1] Sree Balaji Med Coll & Hosp, Dept Biochem, Madras 600044, Tamil Nadu, India
来源
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2015年 / 6卷 / 06期
关键词
Incretins; Insulin resistance; Type II Diabetes Mellitus; pathophysiology;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 2 Diabetes Mellitus (T2DM) is characterized by the decreased responsiveness of tissues to insulin known as Insulin resistance. There may also be Insulin secretary defects in advanced stages. The insulin secretion is initiated by incretins, the two intestinal hormones namely, Glucose dependant Insulinotropic Polypeptide (GIP) & Glucagon like Polypeptide1(GLP-1). They are secreted when food enters the stomach. These hormones are shown to be reduced in T2DM. Hence, the probable role of Incretins in the pathophysiology of T2DM is reviewed here. Many number of studies have been undertaken on the physiology of Incretins and their role in causation of type2 diabetes mellitus. The literature analysis and compilation of results is given here. The level of incretins are much reduced in type 2 diabetes mellitus leading on to reduction in the secretion of insulin and elevation in the level of glucagon. Incretins are necessary to prevent the occurrence of Type 2 Diabetes Mellitus.
引用
收藏
页码:698 / 702
页数:5
相关论文
共 50 条
  • [21] The Pathophysiology of Gestational Diabetes Mellitus
    Plows, Jasmine F.
    Stanley, Joanna L.
    Baker, Philip N.
    Reynolds, Clare M.
    Vickers, Mark H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [22] Role of Magnesium in Type 2 Diabetes Mellitus
    Jianan Feng
    Heyuan Wang
    Zhe Jing
    Yue Wang
    Yanli Cheng
    Wanning Wang
    Weixia Sun
    Biological Trace Element Research, 2020, 196 : 74 - 85
  • [23] Role of Magnesium in Type 2 Diabetes Mellitus
    Feng, Jianan
    Wang, Heyuan
    Jing, Zhe
    Wang, Yue
    Cheng, Yanli
    Wang, Wanning
    Sun, Weixia
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 196 (01) : 74 - 85
  • [24] Incretins and cardiovascular disease: to the heart of type 2 diabetes?
    Solini, Anna
    Trico, Domenico
    Del Prato, Stefano
    DIABETOLOGIA, 2023, 66 (10) : 1820 - 1831
  • [25] Incretins in type 2 diabetes mellitus: cardiovascular and anti-atherogenic effects beyond glucose lowering
    Psallas, M.
    Manes, C.
    HIPPOKRATIA, 2012, 16 (02) : 100 - 105
  • [26] Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
    Frezza, EE
    OBESITY SURGERY, 2004, 14 (07) : 999 - 1005
  • [27] Incretins: a new treatment option for type 2 diabetes?
    Geelhoed-Duijvestijn, P. H. L. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2007, 65 (02) : 60 - 64
  • [28] Incretins and cardiovascular disease: to the heart of type 2 diabetes?
    Anna Solini
    Domenico Tricò
    Stefano Del Prato
    Diabetologia, 2023, 66 : 1820 - 1831
  • [29] Are We Closer to Finding the Treatment for Type 2 Diabetes Mellitus in Morbid Obesity? Are the Incretins the Key to Success?
    Ermenegildo Eldo Frezza
    Obesity Surgery, 2004, 14 : 999 - 1005
  • [30] Incretins: Their physiology and application in the treatment of diabetes mellitus
    Tasyurek, Hale M.
    Altunbas, Hasan Ali
    Balci, Mustafa Kemal
    Sanlioglu, Salih
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (05) : 354 - 371